ALLG Clinical Trials Fellowship Donors

ALLG’s annual Fellowship Program is designed to provide outstanding early-career researchers with a pathway to a career in clinical trial research. The Fellowship will inspire and cultivate the next generation of outstanding blood cancer researchers and clinical triallists to drive better treatments and outcomes for patients with leukaemia, lymphoma, myeloma and other blood cancers.

Research Accelerators

Platinum Accelerators

Hupert Family Foundation

Gold Accelerators

Mark Hertzberg

Silver Accelerators

Peter Kempen

Malcolm McComas

Bronze Accelerators

Devinder Gill

Harry Iland

Edwin Lee

Andrew Roberts AM

Philip Rowlings

Ruth Spearing & Les Snape

Anne-Marie Watson

Deborah White

St Vincent’s Melbourne Haematology

ALLG Accelerators

Amanda Johnston

Douglas Joshua

Lisa Li

Jake Shortt

Nin Younan

David Ward

Andrew Wei

Impact 50 Club

3 year Commitment

Impact Gold 50

Anonymous
Colin Allen
Ken Bradstock
Peter Browett
Adam Bryant
Concord Haematology
Rene Francia
Maher Gandhi
Gareth Gregory
Kate Halford
Tim Hughes
Maya Latimer
Alec Morley
Stephen Opat
Uwe Platzbecker
David Ross
Delaine Smith
Will Stevenson
Judith Trotman
Pauline Warburton

Impact Silver 50

Dennis Carney
Chan Cheah
David Curtis
Janlyn Falconer
Andrew Grigg
Uwe Hahn
John Moore
Tina Rankovic
Philip Thompson
David Yeung

Club 50

Angela Bayley
Michelle Gambrill
Molly Forbes
Elizabeth Fitzsimon
Jennifer Harman
Georgia McCaughan
John Seymour
Rachel Thomas
Tafline Walker
Monique Menzies Wojtowicz

As part of our 50 year anniversary, we were delighted to launch the new ALLG Clinical Trials Fellowship Program. The key priority of the ALLG is scientific advancements in blood cancer research. Our future is determined by how we sustain and develop our workforce and encourage the best and brightest to join our research group and continue our mission to save lives.

Judith Trotman

Chair, ALLG Scientific Advisory Committee